MBCL-11. TIME TO RADIOTHERAPY IMPACTS SURVIVAL IN PEDIATRIC AND ADOLESCENT NON-METASTATIC MEDULLOBLASTOMA TREATED BY UPFRONT RADIOTHERAPY – A REPORT FROM THE HIT 2000 TRIAL
Stefan Dietzsch(Leipzig University), Martin Mynarek(Universität Hamburg), Martin Benesch(St Nicholas Hospital), Robert Kwiecien, Karin S. Kapp(Medical University of Graz), Christiane Matuschek(Düsseldorf University Hospital), Frank Heinzelmann(University of Tübingen), Dagmar Hornung(Universität Hamburg), Matthias Gückenberger(University Hospital of Zurich), Volker Budach(Humboldt-Universität zu Berlin), Nicolas U. Gerber(University Children's Hospital Zurich), Montserrat Pazos(LMU Klinikum), Christoph Pöttgen(University of Duisburg-Essen), Stefan M. Pfister(Heidelberg University), Monika Warmuth‐Metz, Anca‐Ligia Grosu(University of Freiburg), Sabine Klagges(University Hospital Leipzig), Torsten Pietsch(University Hospital Bonn), Heinz Schmidberger(Johannes Gutenberg University Mainz), Rolf‐Dieter Kortmann(University of Turin), Karin Dieckmann(University of Vienna), Beate Timmermann(Essen University Hospital), Jutta Welzel(Pius Hospital Oldenburg), Frank Paulsen(German Cancer Research Center), Carmen Martini(University Medical Center Freiburg), Klaus Pietschmann(Klinikum Chemnitz), Steven C. Clifford(Newcastle University), Katja von Hoff(Universität Hamburg), Felix Placzek(Leipzig University), Karolina Jabłońska, Frank Meyer(University Hospital Augsburg), Rudolf Schwarz(Universität Hamburg), Albrecht Glück(München Klinik Schwabing), Stefan Rutkowski(Universität Hamburg), Juergen Dunst(Martin Luther University Halle-Wittenberg), André O. von Bueren(University of Geneva)
Cited by 0
Related Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k